ASSOCIATION OF NONSWITCHED MEMORY B-CELL (MBC) LEVELS WITH OZANIMOD (OZA) EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (CD): RESULTS FROM THE PHASE 2 STEPSTONE STUDY

Sarah Harris  1     Brian G. Feagan  2     Steve Hanauer  3     Severine Vermeire  4     Subrata Ghosh  5     Jim Yan  6     Chun Wu  1     Yanhua Hu  1     Rachel Maddux  1     Douglas C. Wolf  7     Geert D’Haens  8    
1 Bristol Myers Squibb, Princeton, United States
2 Robarts Research Institute, Western University, London, Ontario, Canada
3 Northwestern University Feinberg School of Medicine, Chicago, United States
4 University of Leuven, Leuven, Belgium
5 APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland
6 Laboratory Corporation of America, Durham, United States
7 Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, United States
8 Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, Netherlands

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing